ArticleCureus2025
Remarkable Response to Radiotherapy With Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Lymphoepithelial Carcinoma of the Hypopharynx in a Nonagenarian.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphoepithelial carcinoma of the head and neck is a rare malignant neoplasm, with primary involvement of the hypopharynx being exceptionally uncommon. While surgery remains the standard treatment, radiotherapy plays a crucial role, particularly for patients who are not surgical candidates. Recent advancements in radiotherapy, such as simultaneous integrated boost (SIB) intensity-modulated radiotherapy, have demonstrated promising outcomes with minimal invasiveness, making them a viable option, especially for elderly patients. This case report describes a 91-year-old female diagnosed with locally advanced lymphoepithelial carcinoma of the hypopharynx who was treated with radiotherapy using SIB intensity-modulated radiotherapy. The patient presented with dysphagia and was found to have a large hypopharyngeal mass with nodal metastasis. Biopsy and immunohistochemical analysis confirmed the diagnosis of lymphoepithelial carcinoma. Given her age and comorbidities, a multidisciplinary team opted for radiotherapy instead of surgery. The prescribed dose was delivered using helical tomotherapy with two gradient doses of 30 gray (Gy) and 35 Gy in 10 fractions utilizing the SIB method. Acute toxicities were mild, and the patient completed the treatment without interruption. Post-treatment imaging revealed a remarkable response, which was sustained for over one year without disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.